Futuretech II Acquisition Corp Total Liabilities

Latest as of June 2025: $10.38 Million USD

Futuretech II Acquisition Corp total liabilities. Based on the latest financial reports, Futuretech II Acquisition Corp (FTII) has total liabilities worth $10.38 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Futuretech II Acquisition Corp (FTII) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Futuretech II Acquisition Corp (2021–2024)

Total liabilities of Futuretech II Acquisition Corp from 2021 to 2024. This chart illustrates how Futuretech II Acquisition Corp's total liabilities have evolved over time, based on quarterly financial data. Explore Futuretech II Acquisition Corp long-term investment intensity to see how much of total assets are deployed in long-term investments.

Futuretech II Acquisition Corp Competitors by Total Liabilities

The table below lists competitors of Futuretech II Acquisition Corp ranked by their total liabilities.

Company Country Total Liabilities
Phosco Ltd
AU:PHO
Australia AU$9.60 Million
Soma Gold Corp
V:SOMA
Canada CA$50.69 Million
Kraft Bank Asa
OL:KRAB
Norway Nkr3.91 Billion
Gogoro Inc
NASDAQ:GGR
USA $463.12 Million
BRAIN Biotech AG
XETRA:BNN
Germany €64.50 Million
Stefstock
JSE:SSK
South Africa ZAC5.08 Billion
Bingshan Refrigeration and Heat Transfer Technologies Co Ltd
SHE:200530
China HK$4.11 Billion
Awanbiru Technology Bhd
KLSE:5204
Malaysia RM88.59 Million

Liability Composition Analysis (2021–2024)

This chart breaks down Futuretech II Acquisition Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see FTII total assets.

Liquidity & Leverage Metrics

Futuretech II Acquisition Corp Total Liabilities Ratios Explained

Futuretech II Acquisition Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 52.06 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.98 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Futuretech II Acquisition Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Futuretech II Acquisition Corp (2021–2024)

The table below shows the annual total liabilities of Futuretech II Acquisition Corp from 2021 to 2024.

Year Total Liabilities Change
2024-12-31 $27.89 Million +400.59%
2023-12-31 $5.57 Million +31.49%
2022-12-31 $4.24 Million +3556.51%
2021-12-31 $115.89K --

About Futuretech II Acquisition Corp

NASDAQ:FTII USA Shell Companies
Market Cap
$51.57 Million
Market Cap Rank
#21578 Global
#4834 in USA
Share Price
$12.02
Change (1 day)
+0.00%
52-Week Range
$12.02 - $12.02
All Time High
$12.65
About

FutureTech II Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on business operating in the technology industry, including artificial intelligence, robotic process automation, biomedical life science, and … Read more